The LARA trial (NCT04699071), a multi-center, single-arm, phase 2 study, found that combining pembrolizumab (Keytruda) with ...

BNY Mellon Core Plus Fund Class I returned 1.04% in Q4 2025. Explore our full market commentary and credit outlook now.

Deal activity, strategic funding and exploration momentum drove strong moves across small cap resources stocks on Friday. Multi-mine gold producer Alkane Resources (ASX:ALK) has moved to increase its ...

Who's got it better in life, kids or adults? A group of fourth-graders in New Jersey did some serious reporting on this topic and sent us their findings as a part of NPR's.

The PIMCO Active Bond ETF provides diversified exposure to investment grade and select high yield debt through an actively ...

Agree Realty stock looks set to outperform with its investment-grade tenants, conservative leverage, and 4.3% yield. Learn more about the trust.

The medical equipment manufacturer published a consumer guide to selecting appropriate oxygen therapy devices, highlighting ...

Doha: The total value of residential sales in Qatar rose by 43.5% year-on-year to QAR 26.6bn in 2025 against a backdrop of expanding supply and softening prices, according to the winter edition of the ...

PFS-level studies are ongoing, with METS Engineering undertaking additional metallurgical test work to build on the high gold recoveries achieved at RPM to date (ASX Announcement: 5 August 2025), ...

In 2026, VARON continues to focus on clarity, reliability, and long-term user support. By offering a clearly structured lineup--from high-performance portable devices to clinical-grade home ...

Verzenio showed promising efficacy in high-grade meningiomas with CDK pathway or NF2 alterations, achieving progression-free survival at six months in 14 of 24 patients. Patients with NF2 alterations ...

Students celebrate at the end of basketball club at Adams Elementary School on Dec. 5, 2025. The Spokane district has ...